Literature DB >> 9593717

Biochemical and structural analysis of the IgE binding sites on ara h1, an abundant and highly allergenic peanut protein.

D S Shin1, C M Compadre, S J Maleki, R A Kopper, H Sampson, S K Huang, A W Burks, G A Bannon.   

Abstract

Allergy to peanut is a significant IgE-mediated health problem because of the high prevalence, potential severity, and chronicity of the reaction. Ara h1, an abundant peanut protein, is recognized by serum IgE from >90% of peanut-sensitive individuals. It has been shown to belong to the vicilin family of seed storage proteins and to contain 23 linear IgE binding epitopes. In this communication, we have determined the critical amino acids within each of the IgE binding epitopes of Ara h1 that are important for immunoglobulin binding. Surprisingly, substitution of a single amino acid within each of the epitopes led to loss of IgE binding. In addition, hydrophobic residues appeared to be most critical for IgE binding. The position of each of the IgE binding epitopes on a homology-based molecular model of Ara h1 showed that they were clustered into two main regions, despite their more even distribution in the primary sequence. Finally, we have shown that Ara h1 forms a stable trimer by the use of a reproducible fluorescence assay. This information will be important in studies designed to reduce the risk of peanut-induced anaphylaxis by lowering the IgE binding capacity of the allergen.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593717     DOI: 10.1074/jbc.273.22.13753

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  Biochemistry of food allergens.

Authors:  J S Stanley; G A Bannon
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

Review 2.  Microbial relatives of the seed storage proteins of higher plants: conservation of structure and diversification of function during evolution of the cupin superfamily.

Authors:  J M Dunwell; S Khuri; P J Gane
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  AllerML: markup language for allergens.

Authors:  Ovidiu Ivanciuc; Steven M Gendel; Trevor D Power; Catherine H Schein; Werner Braun
Journal:  Regul Toxicol Pharmacol       Date:  2011-03-21       Impact factor: 3.271

4.  Generation of mouse-human hybridomas secreting antibodies against peanut allergen Ara h1.

Authors:  Hiroshi Shinmoto; Yasunori Naganawa; Michie Shimmoto; Soheila J Maleki
Journal:  Cytotechnology       Date:  2005-06-16       Impact factor: 2.058

5.  Epitope analysis of peanut allergen Ara h1 with oligoclonal IgM antibody from human B-lymphoblastoid cells.

Authors:  Yasunori Naganawa; Michie Shimmoto; Soheila J Maleki; Masayuki Takase; Hiroshi Shinmoto
Journal:  Cytotechnology       Date:  2008-04-11       Impact factor: 2.058

Review 6.  Bioinformatics approaches to classifying allergens and predicting cross-reactivity.

Authors:  Catherine H Schein; Ovidiu Ivanciuc; Werner Braun
Journal:  Immunol Allergy Clin North Am       Date:  2007-02       Impact factor: 3.479

7.  Computationally predicted IgE epitopes of walnut allergens contribute to cross-reactivity with peanuts.

Authors:  S J Maleki; S S Teuber; H Cheng; D Chen; S S Comstock; S Ruan; C H Schein
Journal:  Allergy       Date:  2011-08-23       Impact factor: 13.146

8.  Epitope analysis of peanut allergen Ara h1 with human monoclonal IgM antibody 92-2.

Authors:  Hiroshi Shinmoto; Yuji Matsuo; Yasunori Naganawa; Shinichi Tomita; Yuko Takano-Ishikawa
Journal:  Cytotechnology       Date:  2009-12-19       Impact factor: 2.058

9.  Characteristic motifs for families of allergenic proteins.

Authors:  Ovidiu Ivanciuc; Tzintzuni Garcia; Miguel Torres; Catherine H Schein; Werner Braun
Journal:  Mol Immunol       Date:  2008-10-31       Impact factor: 4.407

10.  C-Terminal 23 kDa polypeptide of soybean Gly m Bd 28 K is a potential allergen.

Authors:  Ping Xiang; Eric J Haas; Michael G Zeece; John Markwell; Gautam Sarath
Journal:  Planta       Date:  2004-07-14       Impact factor: 4.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.